Evidence map›Paper›PMID 35782104›Full record

ArticleGynecologic oncology reports2022

Massive hypertriglyceridemia associated with paclitaxel; a case report.

Anojian Koneshamoorthy, Danielle Hulse, Chia Yuen Chong, Balasubramanian Krishnamurthy, Sumitra Ananda, Peter S Hamblin

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Gynecologic oncology reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Anojian KoneshamoorthyDepartment of Endocrinology and Diabetes, Western Health, Melbourne, Australia.
Danielle HulseDepartment of Endocrinology and Diabetes, Western Health, Melbourne, Australia.
Chia Yuen ChongDepartment of Medical Oncology, Western Health, Melbourne, Australia.
Balasubramanian KrishnamurthyDepartment of Endocrinology and Diabetes, Western Health, Melbourne, Australia.
Sumitra AnandaDepartment of Medical Oncology, Western Health, Melbourne, Australia.
Peter S HamblinDepartment of Endocrinology and Diabetes, Western Health, Melbourne, Australia.
Western Health · AUEpworth Hospital · AUSt Vincents Institute of Medical Research · AUUniversity of Melbourne · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This report describes a patient who developed massive hypertriglyceridemia (12,488 mg/dL or 141 mmol/L) during paclitaxel and carboplatin adjuvant chemotherapy for high grade serous fallopian tube carcinoma. Paclitaxel was thought to be the causative agent and she had normal triglyceride levels following a change to carboplatin and gemcitabine. To our knowledge, this is the highest reported triglyceride level associated with paclitaxel. Measurement of serum lipids should be considered in individuals receiving taxane chemotherapy, especially in those with type 2 diabetes mellitus or a history of dyslipidemia.

Indexed as

Fallopian tube carcinomaHypertriglyceridemiaPaclitaxel

Identifiers

PMID35782104
PMCPMC9241137
OpenAlexW4283456053

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.